Advertisement

Index by author

March 01, 2009; Volume 37,Issue 3

  1. Abe, Koji

    1. Use of Sandwich-Cultured Human Hepatocytes to Predict Biliary Clearance of Angiotensin II Receptor Blockers and HMG-CoA Reductase Inhibitors
      Koji Abe, Arlene S. Bridges and Kim L. R. Brouwer
      Drug Metabolism and Disposition March 2009, 37 (3) 447-452; DOI: https://doi.org/10.1124/dmd.108.023465

  2. Agarwal, Sagar

    1. Substrate-Dependent Breast Cancer Resistance Protein (Bcrp1/Abcg2)-Mediated Interactions: Consideration of Multiple Binding Sites in in Vitro Assay Design
      Nagdeep Giri, Sagar Agarwal, Naveed Shaik, Guoyu Pan, Ying Chen and William F. Elmquist
      Drug Metabolism and Disposition March 2009, 37 (3) 560-570; DOI: https://doi.org/10.1124/dmd.108.022046

  3. Allen, Darin

    1. Metabolism of (+)-1,4-Dihydro-7-(trans-3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic Acid (Voreloxin; Formerly SNS-595), a Novel Replication-Dependent DNA-Damaging Agent
      Marc J. Evanchik, Darin Allen, Josh C. Yoburn, Jeffrey A. Silverman and Ute Hoch
      Drug Metabolism and Disposition March 2009, 37 (3) 594-601; DOI: https://doi.org/10.1124/dmd.108.023432

  4. Anderson, Alan

    1. Dexamethasone Induction of Murine CYP2B Genes Requires the Glucocorticoid Receptor
      Étienne Audet-Walsh and Alan Anderson
      Drug Metabolism and Disposition March 2009, 37 (3) 580-588; DOI: https://doi.org/10.1124/dmd.108.022772

  5. Audet-walsh, Étienne

    1. Dexamethasone Induction of Murine CYP2B Genes Requires the Glucocorticoid Receptor
      Étienne Audet-Walsh and Alan Anderson
      Drug Metabolism and Disposition March 2009, 37 (3) 580-588; DOI: https://doi.org/10.1124/dmd.108.022772

  6. Bandiera, Stelvio M.

    1. Developmental Expression and Endocrine Regulation of CYP1B1 in Rat Testis
      Grace S. Leung, Masahiko Kawai, Jenny K. Tai, Jie Chen, Stelvio M. Bandiera and Thomas K. H. Chang
      Drug Metabolism and Disposition March 2009, 37 (3) 523-528; DOI: https://doi.org/10.1124/dmd.108.025635

  7. Batard, Yannick

    1. Absorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Humans
      Handan He, Phi Tran, Hequn Yin, Harold Smith, Yannick Batard, Lai Wang, Heidi Einolf, Helen Gu, James B. Mangold, Volker Fischer and Dan Howard
      Drug Metabolism and Disposition March 2009, 37 (3) 536-544; DOI: https://doi.org/10.1124/dmd.108.023010

  8. Bednarski, Patrick J.

    1. Investigation of the in Vitro Metabolism of the Analgesic Flupirtine
      Karen Methling, Przyemslaw Reszka, Michael Lalk, Oldrich Vrana, Eberhard Scheuch, Werner Siegmund, Bernd Terhaag and Patrick J. Bednarski
      Drug Metabolism and Disposition March 2009, 37 (3) 479-493; DOI: https://doi.org/10.1124/dmd.108.024364

  9. Berg, Jeannette Zinggeler

    1. Effect of CYP2A13 Active Site Mutation N297A on Metabolism of Coumarin and Tobacco-Specific Nitrosamines
      Kari E. Schlicht, Jeannette Zinggeler Berg and Sharon E. Murphy
      Drug Metabolism and Disposition March 2009, 37 (3) 665-671; DOI: https://doi.org/10.1124/dmd.108.025072

  10. Berry, Karen

    1. An Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple Dosing
      George R. Tonn, Simon G. Wong, Sylvia C. Wong, Michael G. Johnson, Ji Ma, Robert Cho, Leslie C. Floren, Kathryn Kersey, Karen Berry, Andrew P. Marcus, Xuemei Wang, Bettina Van Lengerich, Julio C. Medina, Paul G. Pearson and Bradley K. Wong
      Drug Metabolism and Disposition March 2009, 37 (3) 502-513; DOI: https://doi.org/10.1124/dmd.108.021931
« Previous (Pages : 1 2 3 4 5 6 ... 19) Next »
Back to top

In this issue

Advertisement